| Descriptor English: | CD52 Antigen | ||||||
| Descriptor Spanish: |
Antígeno CD52
| ||||||
| Descriptor Portuguese: | Antígeno CD52 | ||||||
| Descriptor French: | Antigène CD52 | ||||||
| Entry term(s): |
CD52 Protein CD52, Lymphocyte Antigen CDw52 Antigen CDw52, Lymphocyte Antigen Cambridge Pathology 1 Antigen Campath 1 Antigen Campath 1 Receptor Campath 1H Antigen Campath-1 Antigen Campath-1 Receptor Campath-1H Antigen HLA Bw52 HLA Bw52 Antigen HLA-Bw52 HLA-Bw52 Antigen Lymphocyte Antigen CD52 Lymphocyte Antigen CDw52 |
||||||
| Tree number(s): |
D09.400.430.890.448.190 D12.776.395.550.448.190 D12.776.543.484.500.190 D12.776.543.550.418.190 D23.050.285.022 D23.101.100.943 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000074301 | ||||||
| Scope note: | A small GPI-linked glycoprotein expressed on the surface of normal and malignant B-CELLS; T-CELLS; MONOCYTES; MACROPHAGES; NK CELLS; and GRANULOCYTES. It is expressed densely and without modulation in many malignant T-cell neoplasms and therefore a target for antibody therapies (e.g., ALEMTUZUMAB). |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
| Previous Indexing: |
Antigens, CD (1991-2017) Antigens, Neoplasm (1991-2017) Glycoproteins (1991-2017) |
||||||
| Public MeSH Note: | 2018 |
||||||
| History Note: | 2018 |
||||||
| DeCS ID: | 57128 | ||||||
| Unique ID: | D000074301 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 2018/01/01 | ||||||
| Date of Entry: | 2017/07/11 | ||||||
| Revision Date: | 2017/04/10 |
-
-
CHEMICALS AND DRUGS
Carbohydrates [D09]Carbohydrates -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
|
CD52 Antigen
- Preferred
| Concept UI |
M000626116 |
| Scope note | A small GPI-linked glycoprotein expressed on the surface of normal and malignant B-CELLS; T-CELLS; MONOCYTES; MACROPHAGES; NK CELLS; and GRANULOCYTES. It is expressed densely and without modulation in many malignant T-cell neoplasms and therefore a target for antibody therapies (e.g., ALEMTUZUMAB). |
| Preferred term | CD52 Antigen |
| Entry term(s) |
CD52 Protein CD52, Lymphocyte Antigen CDw52 Antigen CDw52, Lymphocyte Antigen Cambridge Pathology 1 Antigen Campath 1 Antigen Campath 1 Receptor Campath 1H Antigen Campath-1 Antigen Campath-1 Receptor Campath-1H Antigen HLA Bw52 HLA Bw52 Antigen HLA-Bw52 HLA-Bw52 Antigen Lymphocyte Antigen CD52 Lymphocyte Antigen CDw52 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
